SUBSCRIBE
SUBSCRIBE
News   FDA

Mallinckrodt Inc. Painkiller Gets FDA OK

November 2, 2009 | 
1 min read
St. Louis Business Journal -- A generic painkiller developed by Covidien’s pharmaceutical subsidiary, Mallinckrodt Inc., has received approval from the U.S. Food and Drug Administration.
FDA Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
COVID-19
Vinay Prasad Overruled Reviewers on Moderna’s COVID-19 Shot for Kids
July 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
FDA Layoffs, 200 Rejection Letters, User Fees and Priority Vouchers, Bad Week for Rare Disease
July 16, 2025
 · 
1 min read
 · 
Heather McKenzie
Entrance to the U.S. Department of Health and Human Services in Washington, DC
Layoffs
HHS Begins Formally Laying Off Employees
July 15, 2025
 · 
2 min read
 · 
Tristan Manalac
Policy
FDA Commissioner Marty Makary Proposes Lowering Industry User Fees
July 15, 2025
 · 
2 min read
 · 
Tristan Manalac